Answers are grounded in this paper and cite their sources.
Only 31% of the RA patients were assessed in <12 weeks of symptom onset. Assessment in <12 weeks is associated with less joint destruction and a higher chance of achieving DMARD-free remission as compared with a longer delay in assessment. These results imply that attempts to diminish the delay in seeing a rheumatologist will improve disease outcome in patients with RA.
No takes yet. Share an insight, caveat, or question.
Linden et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: